To join this virtual session, please utilize the following link:
https://us02web.zoom.us/j/81050789801
Neurologists, neuromuscular disease specialists, and other healthcare providers who manage patients with gMG
In support of improving patient care, AcademicCME is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
AcademicCME designates this live material for a maximum of 1.0 AMA PRA Category 1 CreditTM.
Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Supported by an independent educational grant from Amgen.
Virtual Session
For all CE inquiries or special needs, please contact admin@academiccme.com.
Discuss the pathophysiology and varied symptom presentation associated with gMG, including the role of autoantibodies and other underlying immune mechanisms
Review strategies for MG diagnosis using a comprehensive approach that includes biomarkers/autoantibody measurement
Evaluate the current standards of care and clinical trial data for emerging therapies to treat patients with MG, including CD19 B-cell depleting therapeutics
Develop strategies to individualize treatments by examining mechanisms of action and patient specifics
To join this virtual session, please utilize the following link:
https://us02web.zoom.us/j/81050789801